These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 18337184

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Peripheral control of inflammatory but not neuropathic pain by endogenous cholinergic system.
    Motta PG, Perez AC, Alves DP, Duarte ID.
    Pharmacology; 2011; 88(1-2):18-25. PubMed ID: 21720188
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain.
    Elmes SJ, Jhaveri MD, Smart D, Kendall DA, Chapman V.
    Eur J Neurosci; 2004 Nov; 20(9):2311-20. PubMed ID: 15525273
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Diphenyl diselenide attenuates acute thermal hyperalgesia and persistent inflammatory and neuropathic pain behavior in mice.
    Savegnago L, Jesse CR, Pinto LG, Rocha JB, Nogueira CW.
    Brain Res; 2007 Oct 17; 1175():54-9. PubMed ID: 17888416
    [Abstract] [Full Text] [Related]

  • 29. H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in rats.
    Hsieh GC, Chandran P, Salyers AK, Pai M, Zhu CZ, Wensink EJ, Witte DG, Miller TR, Mikusa JP, Baker SJ, Wetter JM, Marsh KC, Hancock AA, Cowart MD, Esbenshade TA, Brioni JD, Honore P.
    Pharmacol Biochem Behav; 2010 Mar 17; 95(1):41-50. PubMed ID: 20004681
    [Abstract] [Full Text] [Related]

  • 30. Anti-hyperalgesic effects of intrathecally administered neuropeptide W-23, and neuropeptide B, in tests of inflammatory pain in rats.
    Yamamoto T, Saito O, Shono K, Tanabe S.
    Brain Res; 2005 May 31; 1045(1-2):97-106. PubMed ID: 15910767
    [Abstract] [Full Text] [Related]

  • 31. Possible involvement of increase in spinal fibronectin following peripheral nerve injury in upregulation of microglial P2X4, a key molecule for mechanical allodynia.
    Nasu-Tada K, Koizumi S, Tsuda M, Kunifusa E, Inoue K.
    Glia; 2006 May 31; 53(7):769-75. PubMed ID: 16534777
    [Abstract] [Full Text] [Related]

  • 32. A role for pituitary adenylate cyclase activating polypeptide (PACAP) in detrusor hyperreflexia after spinal cord injury (SCI).
    Zvara P, Braas KM, May V, Vizzard MA.
    Ann N Y Acad Sci; 2006 Jul 31; 1070():622-8. PubMed ID: 16888234
    [Abstract] [Full Text] [Related]

  • 33. Progesterone receptor activation mediates LH-induced type-I pituitary adenylate cyclase activating polypeptide receptor (PAC(1)) gene expression in rat granulosa cells.
    Ko C, Park-Sarge OK.
    Biochem Biophys Res Commun; 2000 Oct 14; 277(1):270-9. PubMed ID: 11027674
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation.
    Geng SJ, Liao FF, Dang WH, Ding X, Liu XD, Cai J, Han JS, Wan Y, Xing GG.
    Exp Neurol; 2010 Apr 14; 222(2):256-66. PubMed ID: 20079352
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The behavioral and neuroanatomical effects of IB4-saporin treatment in rat models of nociceptive and neuropathic pain.
    Tarpley JW, Kohler MG, Martin WJ.
    Brain Res; 2004 Dec 10; 1029(1):65-76. PubMed ID: 15533317
    [Abstract] [Full Text] [Related]

  • 39. Characterization of chronic constriction of the saphenous nerve, a model of neuropathic pain in mice showing rapid molecular and electrophysiological changes.
    Walczak JS, Pichette V, Leblond F, Desbiens K, Beaulieu P.
    J Neurosci Res; 2006 May 15; 83(7):1310-22. PubMed ID: 16511871
    [Abstract] [Full Text] [Related]

  • 40. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats.
    Honore P, Wismer CT, Mikusa J, Zhu CZ, Zhong C, Gauvin DM, Gomtsyan A, El Kouhen R, Lee CH, Marsh K, Sullivan JP, Faltynek CR, Jarvis MF.
    J Pharmacol Exp Ther; 2005 Jul 15; 314(1):410-21. PubMed ID: 15837818
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.